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Background: Most personal care products (PCPs) contain hazardous ingredients, but current legislation in the
European Union (EU) and South Africa (SA) does not require these to be labelled as hazardous products. Instead,
ingredients must only be listed on containers to inform consumers of potential hazards. We assessed whether
current legal strategies provide the means for effective risk communication (RC) mechanisms for PCPs in order to
protect consumers’ health and the environment.
Results and conclusions: RC strategies used in developed countries are not necessarily better compared to
developing countries despite the existence of extensive legislation in the former. Socio-cultural factors, scientific
literacy and language differences are key reasons why the current ingredient lists on PCP labels are not an effective
RC strategy. The assumption is that consumers will interpret the risks of these ingredients by conducting a risk
assessment for their personal context. Realistically, the following risk mitigation measures should be implemented
in developed and developing countries to reduce the public’s potential exposures to hazardous substances:
substitute hazardous ingredients with less hazardous; provide accessible mechanisms for consumers to comprehend
RC measures; delete the exception clause in the EU Regulation on Classification, Labelling and Packaging (CLP); apply
clear mandatory labels where PCPs health risks are clearly illustrated; and increase enforcement of legislation.
The high incidence of fragrance allergies caused by PCPs is one example illustrating how current legal measures in the
EU and SA fail to protect consumers and the environment from hazardous exposures. Therefore, efforts must be made
to improve legally required RC measures.
Keywords: Classification and labeling; Consumer protection; Cosmetics; Developing and developed countries;
Hazardous substances; Personal care products; Risk communicationBackground
Consumers are tasked with risk decision making - whether
they know it or not - every time they purchase personal
care products (PCPs), since many ingredients in PCPs pose
health threats and have the potential to contaminate the
environment. That is, consumers must use the hazard data
provided on the label and make a risk assessment based
on their (and their family’s) own exposures, uses and
physiology. The mechanisms, however, for making these* Correspondence: klaschka@hs-ulm.de
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reproduction in any medium, provided the origdecisions are unknown to the general public, complicated
and inadequate. That is, inadequate to make informed risk
decisions and inadequate to effectively prevent short- and
long-term health effects as well as contamination of the
environment. In this article, we analyze the complexity
and problems for consumers in the European Union (EU)
and in South Africa (SA) to use current hazard informa-
tion on PCPs labels for assessing risks.
PCPs include toiletries, skin care products, hair care
products, decorative cosmetics, and perfumes. Although
this article refers to PCPs to provide a broader under-
standing of the products discussed, the term ‘cosmetics’
is used in both European and South African legislationThis is an open access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
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metics in the European Cosmetics regulation (EC 1223/
2009) [1] and cosmetics in South African legislation
(SA Act 39 of 2007 [2]). These products are readily
available for use on the body and in the mouth for
cleansing, perfuming, correcting body odors and condi-
tions, beautifying, protecting, promoting attractiveness, or
improving or altering a person's appearance. PCP produc-
tion and use is ever increasing globally. In 2010, sales of
PCPs in the EU were over 66 billion Euros, which is a third
of the global PCP market (www.cosmeticseurope.eu).
Although recent data on sale numbers of PCPs in SA are
available in a country report (http://www.euromonitor.
com/beauty-and-personal-care-in-south-africa/report),
accessing these statistics is rather prohibitive for re-
searchers as the cost is 1,800€. Given the wide use and
availability of PCPs, consumers need to both be informed
about potential hazards to human health and the environ-
ment from these products, as well as to know how to re-
duce and prevent risks.
The hazards posed by PCPs depend on the inherent
(eco-)toxicological properties of the ingredients. A hazard
is defined as ‘a possible source of danger’ [3], described
through standardized classification and labelling as pre-
sented by the Globally Harmonized System of Classifi-
cation and Labelling of Chemicals (GHS) [4,5]. Yet the
level of risk caused by PCPs is dependent on consumers’
exposures. If there is no exposure to a dangerous sub-
stance, there is no risk. For some products containing
hazardous chemicals, such as pesticides, a complex and
detailed risk assessment outlining the potential health
and environmental risks is conducted by scientific ex-
perts and presented with the registration application for
these products [6]. In the case of PCPs, however, the
producers conduct a safety evaluation and the hazards
are presented in the ingredient lists on the labels. Con-
ducting of a risk assessment is thus left to the consumer.
However, studies have indicated that consumers perceived
health or environmental risks of PCPs very differently
compared to the scientifically assessed risk from expo-
sures to PCPs [7-9]. This raises the question as to whether
consumers’ human rights are being violated by requiring
consumers to make a risk judgment without the scientific
background or level of literacy required for this task. We,
therefore, argue that appropriate and effective risk com-
munication (RC) mechanisms are needed to correctly
inform consumers. Further, the means for consumers to
understand this information should be provided and re-
quired through various legal instruments. In this article,
we assess whether the type of information provided on
PCP product labels to consumers in the EU and SA is
effective to promote risk reduction decision making and
whether the information is presented in a manner that
is comprehensible by consumers who are heterogeneousin their languages, literacy levels, technical literacy levels,
and visual literacy levels. With global trade in PCPs result-
ing in products being distributed widely, it is important to
compare and contrast RC mechanisms used. This article
concludes with recommendations on how to improve on
the comprehension of risk information among diverse
population groups.
Discussion
Hazardous substances in personal care products
PCPs contain ingredients, such as fragrances, colors, sol-
vents or preservatives, many of which are hazardous sub-
stances or hazardous mixtures with various adverse effects.
Even some natural substances added to these products
can be sensitizers or irritants (e.g., fragrances; [9]). Some
examples of health effects associated with common ingredi-
ents used in PCPs are endocrine disruption [10-13], aller-
gies [9,14-19], associations with asthma [10] and birth
defects [20]. Although, not all consumers develop obvious
negative effects when using PCPs and benefit from these
products, some persons suffer considerable health problems
from the hazardous ingredients in PCPs. Unfortunately,
there are no estimations about the number of unreported
cases. Contact allergy can be linked relatively easily to the
application of certain PCPs containing sensitizers. Approxi-
mately 6% of the general population suffers from contact
allergy due to exposures to PCPs [21]. Other health
effects are more difficult to make a causal link with
certain PCP ingredients. Therefore, most of the publications
about negative effects of PCPs tend to focus on contact al-
lergies, mainly caused by fragrances, dyes or preservatives,
which skews the overall picture of related effects [22-24].
Studies sampling the general population with patch tests
revealed that fragrance allergies to the standard set of
fragrances (i.e., fragrance mix I) is an increasing clinical
problem in many Northern and Southern hemisphere
countries [25]. Furthermore, some of the preservatives
in PCPs (e.g., parabens, formaldehyde), which have a
biocidal action to protect the products against microbial
contamination, are known to be contact allergens and
are found at higher concentrations in products than
needed indicating that they are ‘over preserved’ [21].
Carcinogens, mutagens and substances toxic to repro-
duction (CMR substances) are in principle prohibited
according to the Cosmetics Regulation 1223/2009 [1],
but there are exceptions for these substances where
‘their use has been found safe’ by the Scientific Committee
for Consumer Safety (SCCS) [1]. Mutagens (such as
m-phenylenediamine), carcinogens (such as carbomer)
or substances toxic for reproduction (such as cyclo-
methicone) were listed in formulations of PCPs [26], but
they usually are below the concentration thresholds for
labelling and classification of the mixture thus exposing
uninformed consumers. Butylphenyl methylpropional,
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child (C&L Inventory [27]), is a frequently used masking
agent present in products sold in retail shops where the
exact percentage in the final product is not disclosed. Fur-
thermore, Hutter and colleagues [28] identified synthetic
musks in blood of young healthy adults which came from
cosmetic products applied to the skin. In the USA, a cor-
relation was observed between the use of PCPs containing
estrogens (e.g., placenta or synthetic hormones such as
estron or estradiol) and increased breast cancer incidence
[29]. In another study in the USA, endocrine disruptors,
such as phthalates, parabens or nitrosamines, were identi-
fied in PCPs [30]. Assessing the human health risks posed
by dangerous ingredients in PCPs is an important public
health concern because of the high exposures resulting
from PCP direct application to the human body surface
both intentionally and frequently [31]. Some PCPs are
diluted with water during application (rinse-off products),
such as in the case of shampoo or soap, whereas others
are applied undiluted onto the skin or hair (leave-on
products), as is the case with lotion or deodorant, lead-
ing to higher exposures than rinse-off products. Users
tend to use varied amounts of PCPs and several products
at the same time which leads to a further increase of the
exposure. Furthermore, application of PCPs on children
potentially poses a greater risk of exposure to hazardous
chemicals [32,33]. Therefore, exposures and exposure risks
will vary considerably for consumers using PCPs [34].
RC measures consequently must address these varied
exposures and exposure patterns, as well as differences in
consumer populations (e.g., children, culturally diverse).
The frequent use of PCPs also raises concerns of envir-
onmental contamination, especially water sources, given
the large quantities of products released into sewage sys-
tems and leaching in landfills [35]. Conclusive research on
the extent of dangers for aquatic environments caused by
PCPs is still scarce [36-39]. Extensive and continuous
discharge of PCPs into the water compartment, however,
gives reason for concern as some ingredients are biologic-
ally active compounds similar to pharmaceuticals [36].
Some PCPs are readily degraded; others are persistent
[40]. For example, many studies have been conducted
for synthetic musks highlighting their presence and sta-
bility in the environment and their (eco-)toxicological
effects [41-43]. Cocamidopropyl betaine and lauryl alco-
hol, classified as dangerous for the aquatic environment,
are frequently used as ingredients of PCPs such as
shampoos. The amounts entering the aquatic compart-
ment can be substantial making the relevant concentra-
tions measurable, as is this case with the ingredients
OTNE or HHCB [44]. As the number of ingredients in
PCPs is massive, the task of assessing these risks is
daunting and often beyond budget allocations, particu-
larly in developing countries. Furthermore, the situationand research needs in developed countries compared to
developing countries are impacted by different climatic
conditions, different technical levels of water treatment
and/or various portions of indirect reuse of water. Thus,
prevention of hazardous PCPs entering the environment
is the best strategy.
RC legal instruments
Having outlined the need for better communication of
PCP health and environmental risks to consumers, we
review in this article current RC mechanisms and how
these should be improved.
RC mechanisms in general for PCPs
Legal regulations for RC should bridge the gap between
(eco-)toxicological data generated by experts and risk
perceptions of non-experts. Ideally, products posing no
risks would not require any RC process. Yet, as long as
PCPs pose a residual risk, the legal requirements should
be adequate to ensure that consumers are informed and
are able to understand the information provided in order
to make informed choices. RC is the process through
which individuals are informed about potential hazards
and risks for risk mitigation decision making and man-
agement, often with the intention of provoking safety
behaviors [3,45-48]. The process of communicating risks
is not static, nor are there universally agreed upon ap-
proaches. Over the past 25 years, RC has evolved in devel-
oped countries as RC practitioners continued to identify
more effective strategies. In 1995, Fischhoff listed these
stages, each building on the former, as (1) all practitioners
needed to do was make sure the statistics were right,
(2) all practitioners needed to do was present the statis-
tics, (3) all practitioners needed to do was explain what
the statistics meant, (4) all practitioners needed to do
was show that similar risks had previously been accepted,
(5) all practitioners needed to do was illustrate that the
risk is good for those exposed, (6) all practitioners needed
was to treat those exposed nicely, (7) all practitioners
need to do is make those exposed to the risk partners,
and (8) all practitioners need to do is incorporate all of
the above stages [49,50]. The more recent literature on
RC indicates that it should be a two-way process - that
is, a process that involves consultation with and participa-
tion by the general public/consumers [3,46]. This could be
seen as falling under Fischhoff ’s seventh stage. In devel-
oping and low-middle-income countries like SA, how-
ever, the RC process has not evolved and tends to be at
Fischhoff ’s stages 1 and 2 - that is, risks are communi-
cated through a top-down approach (one-way communi-
cation), or risk information is just presented (i.e. listed on
the label) [46]. In the EU, the recognition of consultation
and participation is referred to in several documents ra-
ther than implemented in practice. This is particularly
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lip service to Fischhoff ’s stage 7. The reality is that
two-way RC is costly and time consuming. Thus, the
challenge is to move from policy to practice in order
to protect consumers.
There exists an array of guidance on risk and hazard
communication which influences country-specific legis-
lation. PCP risk information is currently communicated
to consumers differently and with different standards
depending on country-specific legislation. Our intention
is not to describe the legal instruments in detail, but rather
to highlight some essential elements needed for labeling
of PCPs to be an effective RC mechanism. The OECD
guidance on RC for chemical risk management [51], for
example, determines various types of risk situations where
RC is recommended. The situation for PCPs corresponds
to the so-called ‘routine RC’, where the ‘risks are well
known to scientists, risk managers are aware of the
potential consequences and few uncertainties remain’.
This implies that a proactive communication with the
general public should be embarked on [3].
In order to develop appropriate RC mechanisms for
PCPs, these need to incorporate several key issues and ad-
dress key questions for each. These are:
(i) Residual risk: Which risk is an unavoidable residual
risk? Which risk is acceptable based on the use
context? Who should decide which residual risk is
tolerable/acceptable (government officials,
manufacturers, scientists, NGOs or consumers)?
How did policy interpret the complex scientific
information to develop legal standards?
(ii) Type and presentation of information: How is the
information presented and where? Who determines
what is put on a label? Is the design of a product
consistent, or does it look harmless, even if it
contains hazardous substances? How are diverse
cultures and literacy capabilities addressed? What
mechanisms are put in place to aid the
understanding of the information?
(iii) Receivers: Is there a culture of reading labels
amongst consumers? Is the language of the label
technical or easily understood by all consumers?
Does the understanding lead to a safer handling of
the products? [45]
(iv)Messengers: Who is providing the information?
How do consumers view/respect this information
provider? Are they trusted? [45]
(v) Aims: How important is the safety for consumers in
the RC process? How important is the protection of
the environment? What are the economic and
other interests?
(vi) Feasibility: Who is responsible for the control?
Who pays for it? Are there effective penaltiesthat lead to a better conformity with the legal
requirements in the future? Who monitors the
relevance and updating of the information
provided?
Examples of legal RC mechanisms
EU PCP ingredients in the EU are regulated like other
substances by the relevant chemical legislations (see below
REACH [52] and the EU Regulation on Classification,
Labelling and Packaging (CLP) [53]). When these ingre-
dients, however, are used in cosmetic products, they are
regulated under the Cosmetics Regulation which does
not require risk assessments but a ‘safety evaluation’ by
a competent safety assessor [1]. This evaluation mainly
considers irritation and contact allergy, while other pos-
sible effects on human health or the environment need
not be assessed [54-56]. Considering the required ad-
ministration of vast amounts of data for all chemicals,
better coordination of these regulations would go a long
way to promote effective PCP risk management [57].
Ingredients of PCPs are good examples to show how
difficult it is to regulate chemicals through legal in-
struments such as REACH and respective product reg-
ulations. Manufacturers establish product safety according
to safety assessments [58]. From a scientific perspective,
it is generally not possible to prove a chemical to be
‘safe’. Instead, it is only possible to indicate that no risk
has been identified thus far. We, therefore, recommend
the wording ‘risk assessment’ be used instead of ‘safety
evaluation’. On the other hand, causation between a
chemical in a certain product linked to a specific health
effect is difficult to prove. More than 1,300 hazardous
substances are prohibited (e.g., lead and its compounds)
according to the EU cosmetics regulation. A further 150
chemicals require exposure risk mitigation measures
which means that they may only be used under certain
conditions (e.g., formaldehyde or methanol in Annex III
of the Cosmetics Regulation: list of substances which
cosmetic products must not contain except subject to
restrictions laid down; [1]). Currently the main RC mech-
anism for PCPs is the product label ingredient list listing
names as specified in the INCI-List (Inventory and a
Common Nomenclature of Ingredients employed in Cos-
metic Products) [59]. A specific requirement in relation
to PCP ingredient lists has been the ‘26 allergens rule’
[60,61]. This is part of the cosmetics regulation and re-
quires that 26 potential allergenic fragrance substances
be listed on labels if they are present above 0.001 percent
in ‘leave-on’ products (e.g., lotions) or above 0.01 percent
in ‘rinse-off ’ products (e.g., shampoos). The amounts
are not indicated on the label and there are no maximum
concentration limits for all of them. Consumers also re-
ceive information about shelf lives and specific safety
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‘Examples of ingredient lists from the EU and the USA’
illustrates a hypothetical PCP ingredient listing commonly
found on labels. The assumption is that consumers will
evaluate these ingredient lists, identifying potential haz-
ards, and assess which chemicals pose a risk for them
personally. Then, after identifying these risks, based on
their exposures and own health status, they will either
not buy the product or implement an effective and scien-
tifically proven risk mitigation strategy. These are onerous
and unrealistic assumptions for consumers to execute.
The ‘26 allergens rule’ [60,61] is part of the cosmetic
regulation and requires that 26 potential allergenic fra-
grance substances must be named on the labels if they
are present above 0.001 percent in ‘leave-on’ products
such as lotions or above 0.01 percent in ‘rinse-off ’ prod-
ucts such as shampoos. The amounts are not indicated
on the label and there are no maximum concentration
limits for all of them.
Examples of ingredient lists from the EU and the USA
The following are the acceptable ingredient listing adapted
from [62]:
1. Acceptable in the EU only. The following are the
ingredients: aqua, alcohol denat., Hamamelis
virginiana, sodium PCA, mel, Prunus amygdalus
dulcis, Paraffinum liquidum, Melaleuca alternifolia
oil, parfum, phenoxyethanol, methylparaben,
propylparaben, limonene, linalool, cinnamal,
alpha-isomethyl ionone, CI 17200, CI 42090
2. Acceptable in the EU and the USA. The following
are the ingredients: aqua (water), alcohol denat.,
Hamamelis virginiana (witch hazel) extract, sodium
PCA, honey (mel), Prunus amygdalus dulcis (sweet
almond) oil, Paraffinum liquidum (mineral oil),
Melaleuca alternifolia (tea tree) leaf oil, parfum
(fragrance), phenoxyethanol, methylparaben,
propylparaben, Limonene, linalool, cinnamal,
alpha-isomethyl ionone, CI 17200 (red 33), CI
42090 (blue 1)
Cosmetic products need not be classified and labelled in
accordance with CLP [53], even if they contain dangerous
substances above the classification thresholds. In contrast,
other consumer products, such as glue or varnish, are
classified and labeled but not required to have the list of
ingredients on their container labels. If, however, PCPs
were classified and labelled in accordance with the CLP,
many of them would require hazard pictograms on the
label [26].
Many ingredients of PCPs are self-classified by pro-
ducers resulting in the CLP entries in the Classification
and Labelling Inventory being continuously updated. Theoutcome is that final classifications of the products are
not consistent yet. Recent self-classifications made by
the majority of suppliers tended to be less severe [63] so
that the final classification of some products will be less
severe as described by Klaschka [26]. As some PCPs
contain hazardous substances above the threshold for
labeling, the EU legislators made this exception in the
CLP Regulation. Otherwise, an exception would have
been superfluous.
The registration of cosmetic ingredients, according to
the EU chemicals regulation (Registration, Evaluation, and
Authorization of Chemicals, REACH) [52], may lead to
more publically available information. However, several
waiving conditions will apply to quite a number of cos-
metic ingredients, (e.g., fragrances). Therefore, it cannot
be taken for granted that the data situation will improve
for all PCP ingredients [64]. In addition, according to
REACH, the chemical safety report does not need to
consider the risks to human health from the use of cos-
metic products ([52] Chapter 1 Article 14 5(b)). As a re-
sult, REACH will not significantly contribute to reducing
the current lack of risk information for ingredients in
PCPs. According to REACH, RC is required if existing
communication mechanisms are not being implemented
effectively [3]. In the situation of PCPs, it must be ques-
tioned whether consumers are supplied ‘with sufficient
information to handle chemicals and articles containing
the most hazardous substances safely’ ([3] Page 10). In
this case, member states could decide to introduce RC
instruments before a harmonized solution is agreed
upon under REACH [3] and may be a prime opportunity
to improve PCP RC.
SA As in many other countries worldwide, ingredient lists
are legally required on PCPs also in SA, although the
detailed requirements vary. Communicating the chemical
hazards of PCPs tends to be more of a legalistic require-
ment rather than ensuring that consumers are able to
protect their health and the environment from these
hazards. In the South African National Standard on
Ingredient labeling of cosmetic products (not yet pro-
mulgated into law), the purpose of ingredient labeling
is cited as ‘to ensure transparency to the consumer, to
give adequate information about the product, and to
avoid purchase of a product that contains an ingredient
that the consumer does not wish to use’ [62]. What is
rather alarming is the reference that the label allows a
consumer to avoid purchasing a PCP containing ingre-
dients the consumer wishes not to use. Firstly, the onus
is put on the consumer to have the knowledge of un-
wanted or hazardous ingredients, and secondly, the as-
sumption is that all consumers can read PCP ingredient
lists as a toxicologist or eco-toxicologist. Furthermore,
transparency is not defined in this standard but the
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the label, the consumer will be able to make an informed
decision and know whether to avoid exposure. The reality
is that SA is more interested in exporting cosmetics to the
EU and the USA indicated through the emphasis on using
labeling to comply with EU and harmonized INCI nomen-
clature. SA is addressing this issue with PCPs by adopting
legislation that requires labeling more consistent with
the EU and harmonized INCI nomenclature (see ‘Examples
of ingredient lists from the EU and the USA’ section; [62]).
Comparison of the situation in the EU and SA The
‘guidance on the communication of information on the
risks and safe use of chemicals’ developed by the European
Chemicals Agency (ECHA) in the context of REACH [3]
offers a theoretical approach for chemical RC. The pur-
pose of this document is to help Member States Compe-
tent Authorities to communicate chemical risks to the
public. The approach proposes four steps: (1) Understand
the issue; (2) Determine the communication needs; (3)
Implement RC; and (4) Evaluate and review. These steps
are a useful exemplary structure for the analysis of RC
mechanisms for PCPs as is illustrated in Table 1. The first
column shows the general actions for RC recommendedTable 1 ECHA recommended actions for RC and simplified co
ECHA recommended
actions





Detailed knowledge about ingredients
obtained by standard laboratory tests or
computational models is needed for sound









The public should be able to make
informed choices. This implies the need for
comprehensible RC mechanisms to
consumers. RC should help to reduce the




Step 3: Implement RC Legal regulations should lead to a high










Step 4: Evaluate and
review
Authorities should enforce and control the
implementation of legal instruments. They
should control whether the intended goals
of risk reduction were reached and evaluate
consumer comprehension of risk
information. If necessary, new ways of RC












Sources: [1,3,52,53,62].by ECHA. In the second column, we illustrate what the
direct application of these recommendations for PCPs
would look like. Columns three and four give a brief over-
view about the current situation in the EU and in SA in
relation to the ECHA recommended steps. Step one re-
quires that the issue is well understood by Member States
Competent Authorities based on the scientific data in
relation to PCP ingredients, although the data availability
is not as straightforward as for other chemicals [54,57]. In
steps two to four, there is a big discrepancy between the
recommendations by ECHA and the actual situations in
the EU and SA, illustrating that PCPs RC is not in line
with ECHA recommendations.
Other countries In the USA, additional English common
names are required in brackets to assist consumers with
understanding complex ingredient names (see ‘Examples
of ingredient lists from the EU and the USA’ section).
However, analytical screenings found that the ingredient
lists are not always complete, and phthalates and fra-
grances are often not properly listed [10]. The Inter-
national Cooperation on Cosmetic Regulation (ICCR),
an international group of regulatory authorities from
Canada, EU, Japan and the USA, is attempting to promotemparison with current status in the EU and in SA
t status in the EU Current status in SA
oxicological data on ingredients are
le to the producer, the Competent
rities and the informed public.
ers test their products and consider
as safe. Various stakeholders have
nt interests.
Actions rely on the industry to
adhere to self regulation.
substances are banned or restricted
ing to the Cosmetics Regulation.
Follows EU regulations.
gredients must be listed on the PCPs.
ential allergenic fragrances must be
y name on the PCPs. PCPs need not
sified and labelled according to the
gulation. No exposure estimation to
s is needed according to REACH.
evaluation is performed according to
smetics Regulation.
Follows EU labeling.
are product spot checks by
ities, but the control of consumer
ehension and protection is not
l part of the official RC process for
nly some independent research
s conducted surveys. The
nmental concentrations are reason for
n for some cosmetic ingredients. The
rs of patients with contact allergy
her negative health effects caused by
ients of cosmetic ingredients are high.
Consumer comprehension of
label information is not
evaluated. There is no research
on improving RC mechanisms
for PCPs.
a) b)
Figure 1 GHS pictogram (exclamation mark) (a) and EU
standard hazard symbol (St. Andrew’s Cross) (b). (a) This
pictogram is a symbol for acute toxicity, skin corrosion/irritation,
serious eye irritation, skin sensitization, or specific target organ
toxicity (single exposure) according to the GHS [4,53]. (b) This is the
symbol for harmful or irritant chemicals according to Council
Directive 67/548/EEC [68].
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barriers to international trade. The focus of this group
is currently on safety assessment with three outcomes
relevant for RC labelling of PCPs:
– The product is safe for the proposed use without
restrictions.
– The product is safe with restrictions and may
need specific warnings or precautions (risk
reduction measures).
– The product is not safe.
The safety statement ICCR is considering to include
on PCPs is
After analysis of all available information including
formulation, toxicological profile of the ingredients and
clinical reports, it is concluded that, according to the
current state of scientific knowledge, product XXX is
not expected to cause damage to the human health
and can be marketed for the intended and foreseeable
use as [insert product type] [65].
These initiatives of the ICCR focus more on promoting
trade than ensuring consumer safety and environmental
protection through appropriate RC mechanisms on the
label that are comprehensible by the consumer. Nor are
manufacturers required to identify hazardous substances
through signal words, precautionary statements or picto-
grams as is the case with non-PCP hazardous substances
(e.g., pesticides, industrial chemicals). Globally, there is a
trend to harmonize labelling of products containing
hazardous chemicals in order to promote trade. The as-
sumption is that harmonizing labels will also promote
effective RC.
Consumer comprehension of hazard information
Consumers’ right to know
The right-to-know movement of the 1970s began in the
USA for the general public to have access to information
in regard to hazardous chemicals, toxic emissions and
placement of toxic factories, which became legislated under
RC laws. This movement, however, has not extended to
PCPs. We argue in this article that consumers have the
right to be informed about the potential health and envi-
ronmental risks posed by the PCPs they use. What is key
is that consumers are not only provided with the rele-
vant hazard information, but that the information is
presented so that a non-scientific lay person can under-
stand the information in order to make a risk assess-
ment. If information provision is solely to protect the
liability of industry or fulfill some legislated obligation,
then the consumer is not being taken into account. In
reality, many consumers are unaware of the potentialhealth effects (acute and chronic) and whether the use
of these products is contributing to environmental con-
tamination. Effective RC mechanisms are an important
step to improved protection of the environment and the
health of the consumers, but providing information is
not enough. Consumers need to be able to understand
the information and know what their options are.
In the European or South African legislation, there are
currently no requirements for evaluating whether and
how the general public understands the ingredient infor-
mation on labels and how to use this information (see
Step 4 in Table 1). It is therefore difficult to assess whether
this type of RC leads to reduction of risks or not. The
study by the European Agency Communication on the
Safe Use of Chemicals revealed that the majority of the
general public misinterprets pictograms of the CLP regu-
lation [66,67]. For example, only 11% understood the
meaning of the GHS acute toxicity pictogram frequently
found on consumer products (GHS07; exclamation mark;
Figure 1a) [66,67].
Other surveys assessing how hazard labels are perceived
by the end-users revealed that pictograms are not well
understood by the majority of the general public or the
receivers as these are not intuitively obvious or cross-
culturally transferable [45,66,69]. A South African study
illustrated, through a mental models approach, how the
scientifically intended meanings of pesticide label picto-
grams (based on risk assessment data) are mis-interpreted
by farm workers [69,70]. For example, 36% of respondents
did not know the UN Food and Agricultural Organization
pictogram for harmful (i.e., the St. Andrew’s Cross,
Figure 1b), while 31% gave an incorrect interpretation
(some definitions included ‘for emergency, first aid kit,
shows hospital, don’t use, do not enter where this sign is
shown’ [69]. This study emphasized the point that RC
mechanisms are not self-explanatory and do not take
into account varying literacy levels and languages of
end-users. For RC mechanisms to be understood as
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with the means to interpret this information [45].
As contact allergy is a common result of exposures to
fragrances and because of the European ‘26 allergen
rule’ , the comprehension and effectiveness of the declar-
ation of fragrances on PCPs was analyzed in several
studies. Noiesen conducted a survey to find out whether
Danish patients with allergic contact dermatitis could use
the names of the allergenic fragrances listed on the con-
tainers to prevent harmful exposures. One finding was
that patients with lower educational levels found it
difficult to read the names of the chemicals on the
containers, despite being trained on the INCI names. Fur-
thermore, only half of the interviewees trusted the correct-
ness of the information in the ingredient lists [7]. This
illustrates that either the public does not trust the source
of the information and/or that a specific fragrance that is
below the threshold for declaration on the product might
still elicit symptoms. In Lysdal and Johansen’s [8] survey
with patients suffering from a fragrance contact allergy,
most respondents said that ‘a more clear labelling of the
fragrance ingredients would increase their benefit’. Of the
patients interviewed, 56% indicated that they identified
fragrance appropriate products by trial and error, com-
pared to 35% who used the ingredient lists. Nardelli and
colleagues [71] illustrated how the names of the allergenic
fragrances on products used by patients assisted dermatol-
ogists with identifying the causal allergens. Thus, scientif-
ically trained persons are more likely to use ingredient
lists as intended but not average consumers. Although,
the ‘26 allergens rule’ has its limitations, there are other
products that do not require that fragrances be declared
at all (e.g., paper or textiles) [72] and so this is at least a
step in the right direction.
‘Read this and be safe!?’
The findings from the above studies illustrate that the
general public are not all able to read the ingredient lists
on the labels nor understand the implications of these in
order to use the products in a low-risk manner. We pos-
tulate that they are not even aware that they are tasked
with conducting risk assessments, risk control and risk
management. Consumers not only lack access to adequate
information to make these assessments and safety mea-
sures, but they also often lack the numeracy and health
literacy skills required to understand the information.
The situation for PCPs is further aggravated by con-
sumers being misled about the product safety from the
attractive containers, appealing messages promised by
the cosmetic industry, and the lack of warning symbols
[33,66,67]. These messages tend to make consumers trust
the products and make them less aware that they might
contain dangerous substances. However, in some coun-
tries, particularly developed countries where consumershave access to risk information through the internet,
risk perceptions towards PCPs might be changing. A re-
cent survey among American female students revealed
‘that nearly half of the respondents do not believe that the
government adequately regulates personal care products
(45.5%) and over half do not feel that they know all they
need to know about the ingredients in the personal care
products they use (62.5%)’ [34]. In this study, only less
than 5% were not at all concerned about health and envir-
onmental risks posed by PCPs.
The example of a hypothetical ingredient list in the
‘Examples of ingredient lists from the EU and the USA’
section illustrates that consumers not only need to under-
stand technical jargon, but they also need to have a scien-
tific background (and good internet access) to know what
these chemicals are and what role they play in the
product. The USA label requirement at least provides
common names for the ingredients in brackets to assist
consumers with ingredient identification. Generally, and
particularly in low-to-middle income countries such as
SA, consumers will not be able to use the ingredient
listing for any meaningful risk decision making as a result
of lack of noticing the information and lack of compre-
hension of the information [45,69,73]. Whether the gen-
eral public in the EU is able to use these lists adequately is
also questionable.
What consumers need for understanding ingredient lists
The list of ingredients on the containers of PCPs is a
means for consumers (e.g., for consumers with allergies)
to establish the hazard and then assess their personal
risk. What is needed is a method for all consumers to
quickly interpret the meanings without having to access
other resources (e.g., the internet, phone help line or
poison centre). Consumers are not a homogenous group,
and yet with the advent of the GHS, there are more and
more efforts to standardized RC mechanisms globally to
enhance trade [45]. Legislating risk information on PCP
labels presumes consumers have the basic skills to under-
stand risk information. In order to understand and to
know what to do with this information, a consumer, re-
gardless if they are from the EU or SA, would require
the following basic knowledge and skills:
Adequate literacy levels In order for consumers to know
that the label is providing risk information they need to
read [73]. Secondly, the consumer must be able to read
the language of the label. For labels using pictograms or
colour to express risk/toxicity information, visual literacy
is required [46].
Knowledge of labels as a RC tool Consumers first need
to know that a label is providing risk information to pro-
mote informed decision making. In some countries (e.g.,
Klaschka and Rother Environmental Sciences Europe 2013, 25:30 Page 9 of 18
http://www.enveurope.com/content/25/1/30SA), there is not a culture of reading labels [46,73]. Labels
are rather seen as just providing the product name and
use instructions. PCP labels are not user friendly as illus-
trated by the ingredient lists made up of technical names.
Many consumers are also unaware that label ingredients
are listed in order of volume of the total product.
Means to comprehend What mechanisms are available
to consumers to understand PCP labels? For consumers
in a medium to high socio-economic bracket they may
have access to the internet. This is, however, not the case for
the majority of consumers in SA. What guidance is available
to read and understand the hazardous chemical ingredients
and explain how this information should be used?
Motivation to comprehend There are several elements
which play a role in consumers using a PCP label to in-
form themselves about the potential risks. These include
(a) a culture of reading labels, (b) an awareness that they
provide hazard information and the expectation to receive
a personal benefit, (c) a previous history/experience of a
PCP causing a health effect to oneself or another, and
(d) the time to engage with the information. Time is an
important factor in the motivation to comprehend or to
not bother trying to comprehend label information. How
much time would a person with higher/lower education
level have to invest to be informed - for example, when
buying a deodorant? How much time do consumers really
invest to inform themselves? People who have suffered
health effects from PCPs are more motivated to inform
themselves about the risks and to seek out information on
particular ingredients [7].
With the two following frequently used fragrance in-
gredients in cosmetic products, we provide examples of
what should be known about the risk when applying such
substances regularly to one’s body surface. These two
fragrance ingredients must be named on EU labels ac-
cording to the ‘26 allergens rule’ [60,61]:
 The first example, Limonene (CAS 5989-27-5), is
found in shampoos, washing and cleansing products,
‘air fresheners’ and products other than PCPs where
there are no legal requirements for declaration on
the products. Limonene is classified and labelled as
H226 (Flammable liquid and vapour), H315
(Causes skin irritation), H317 (May cause an allergic
skin reaction), H410 (Very toxic to aquatic life with
long-lasting effects) and must be labelled with three
pictograms in the pure state (GHS02 (flame), GHS07
(exclamation mark), GHS09 (risk for the environment)).
In addition, its oxidation products can have higher
sensitizing potentials.
 The second example, Hydroxyisohexyl-3-cyclohexene
carboxaldehyde (synonym: 4-(4-Hydroxy-4-methylpentyl)cyclohex-3-enecarbaldehyde (CAS
31906-04-4), is classified as H317 (May cause an
allergic skin reaction), H319 (Causes serious eye
irritation), H412 (Harmful to aquatic life with
long-lasting effects) must be labelled by the GHS07
(exclamation mark) pictogram in the pure state. In
case the consumer suffers from a contact allergy she
or he should know that a doctor calls this substance
Lyral or HMPCC, whereas the INCI name
Hydroxyisohexyl-3-cyclohexene carboxaldehyde is
written on the products.
In theory, consumers should use this information to
make their own risk assessments in relation to each ingredi-
ent, the synergistic effect of the ingredients and the cumu-
lative effect from exposures to other products containing
these ingredients. Not only is this a complex task for a con-
sumer, but there is limited research as to the synergistic
effect of two or more hazardous chemicals contained in
one product. Also, toxicologists and ecotoxicologists are
not able to do such a risk assessment ad hoc, as an
exposure-effect assessment is required with the estimation
of a safe exposure level. Thus, expecting a consumer to do
this illustrates that current ingredient lists on PCPs are
not a viable RC mechanism and may well violate the rights
of consumers.
Consumers’ risk perceptions
The concept of risk has a clear meaning in the technical
sciences, but for consumers, the concept of risk is often
confused with hazard, referred to as danger when trans-
lated into local languages, experience-related and persuaded
by social communication [46,66,74,75]. Social and cul-
tural factors, which are regularly swayed by media reports,
peer and family influences and other communication
mechanisms, have more of an impact on consumers’ un-
derstanding of risk than legislation and scientific data
[70]. Labels on PCPs, as a risk communication tool, have
been developed based on a technical rationality of risk, to
influence consumer product use behaviours. Consumer
risk behaviours, however, are not persuaded by risk infor-
mation only and without understanding the interaction
between RC mechanisms and consumer risk perceptions,
the label is further rendered ineffective [45,46]. For ex-
ample, a study in several European countries showed the
correlation between risk perception and safety behavior
was low [66]. What needs to be taken into account is how
risk perceptions influence the understanding of RC mech-
anisms and what consumers’ perceptions are of the ingre-
dient lists, hazards symbols (Figure 1a,b) and any other
method used to communicate risks [45]. The question is
whether current labelling is more for protecting the
industry from liability rather than acting as an effective
RC mechanism to consumers. This being the case,
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are required. Detailed analyses are urgently needed to as-
sess whether consumers’ (whether in EU or SA) risk per-
ceptions correspond to the potential risks of hazardous
substances in PCPs in order to improve on current RC
mechanisms.
Recommendations for mitigating risks
PCP RC in general
Socio-cultural, scientific literacy and language differences
are key reasons why the ingredient lists are not a satisfac-
tory RC strategy for PCPs. The comparison of the situ-
ation in developed and developing countries illustrates
that RC is not necessarily better in developed countries
despite the existence of extensive legislation. There are
several risk mitigation measures that should be imple-
mented as an integrated management strategy rather than
focusing on only one approach to improve the situation.
For example, there are some proposals on how to reduce
risks posed by fragrance allergens in PCPs [64]. An
effective RC process should be transparent and easily
understandable by all target groups. It should use simple
and clear language [3]. Furthermore, consumers should
not be required to conduct risk assessments. Rather, PCPs
should be required to be registered and overseen by a
regulatory body that is able to assess the risks for the local
populations and ensure a safe product assortment. In the
case of PCP ingredients where there is unacceptable un-
certainty about the potential hazards, the precautionary
principle should be applied. RC is not context neutral
[45]. We suggest that legal instruments for regulating
PCPs be structured so as to take into account the use con-
text, literacy levels, formal education, cultural factors, etc.
of the consumer when developing RC mechanisms. This
would include regular surveys to find out in what way the
users comprehend the information/mechanisms and
whether their designs would need adjustments. In our
opinion, this internal control ought to be an inherent
element in the RC process as no hazard or risk commu-
nication mechanism will ever be inherently obvious to
the consumer. Aiding comprehension needs to be an inte-
gral and legislated component of PCP legislation. In reality,
risk communication mechanisms are not cross-culturally
transferable. Thus in a bid to promote and minimize trade
barriers, consumer health and safety will be compromised.
Methods to promote comprehension could include printed
information, websites and other electronic communica-
tions, surveys and focus groups, public presentations and
discussions, education and training, press releases and
media interviews and press conferences [3].
Reduction of dangerous chemicals in consumer products
The best way to reduce risk is to keep the residual risk
as small as possible through reducing the amount ofhazardous substances in the product [32,76]. This should
be the first step before using RC mechanisms as risk reduc-
tion measures. For example, allergen avoidance prevents
the acquisition of contact allergy of healthy individuals
in the general population and helps to reduce the occur-
rence of symptoms in sensitized persons.
Substitution of dangerous substances by less hazardous
substances is not always easy, but should be the first pri-
ority [52,77]. CMR substances, for example, should not
be present in any PCPs and the exceptions allowed in
the Cosmetic Regulation should be deleted. In the case
of PCP ingredients where there is uncertainty about the
potential hazards, the precautionary principle should be
applied and these ingredients should be limited. Where
compliance and enforcement of legislation is problematic,
particularly in developing countries, highly hazardous
ingredients should not be allowed for use in PCPs. Haz-
ardous substances should not be substituted by substances
of similar hazards, such as isoeugenol derivatives as sub-
stitutes for isoeugenol, as this does not reduce the risks to
consumers and the environment [78,79]. We postulate
that stricter standards are needed for people who want to
use less toxic products and for vulnerable populations
such as babies and children, pregnant women [32,33],
people with respiratory problems, allergic people, as well
as malnourished and immune-compromised populations.
Labels
As has been illustrated, provision of an ingredient list
is not adequate to inform consumers of potential risks.
Labels need to spell out the risks. Mechanisms need to
explain what the risk information on the label means,
why safety behaviours are required and what these safety
behaviours are. Boelhouwer and colleagues [80] illustrated
in two US surveys that hazard and precautionary labels
may improve risk communications. However, it is interest-
ing to note that the OECD guidance document on risk
communication for chemical risk management [51] does
not mention labelling of products as a risk communica-
tion method.
A step towards a better RC would be to delete the ex-
ception clause in the CLP-regulation for cosmetic prod-
ucts and to apply the hazard labels also for containers
smaller than 125 mL [26]. The intention would be that,
with time, consumer preference for less hazardous products
would lead to a shift to manufacturing of less hazardous
PCPs. The CLP currently does not allow that containers of
hazardous products look harmless. If the exception in the
CLP Regulation were deleted, it would be legally required
that the design of PCP containers should highlight the
risk messages on labels and not attempt to detract from
the risk messages.
The CLP Regulation allows for up to six precautionary
(P-) statements on the labels of hazardous products.
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for drawing consumers’ attention to potential risks. When
applying the classification criteria of the CLP Regulation
to PCP formulations, several products would have to be
labeled with hazard (H-) statements [26,63]. Each H-
statement leads to a set of P-statements [53]. Table 2
illustrates examples of potential P-statements for some
PCPs resulting from the respective H-statements. It is
evident that some of the P-statements would not be realis-
tic for the normal application of PCPs. For example,
hairspray producers would have to cite on the label the
recommendation ‘Wash … thoroughly after handling (P264)’
or ‘Wear protective gloves/protective clothing/eye protection/
face protection’ (P280). Also, the P-statement ‘Avoid breath-
ing dust/fume/gas/mist/vapours/spray’ (P261) would be diffi-
cult to apply to perfume. Furthermore, many consumers
apply perfume to the skin which does not correspond to
the P-statement ‘IF ON SKIN: Wash with plenty of soap
and water’ (P302 + P352). These examples indicate that
some application patterns of PCPs are in contrast with
the recommendations in the precautionary statements.
A further problem with the P-statements is they lack
enough detail to evoke the intended safety behavior. For
example, ‘wear protective gloves’ does not indicate what
type of material the gloves should be made of. In countries
such as SA where there are 11 official languages and
low literacy levels amongst the consumer population,
P-statements alone would not assist with increasing
consumer understanding of risk [46,69]. Even if compli-
ance of users with P-statements may be imperfect [81], it
is better to provide risk information than none. Advice
on how to reduce exposures would also aid consumers
in risk reduction. Thus, rather than change behaviours,
risk reduction should occur through replacing hazard-
ous ingredients in products.
Pictograms
Adding pictograms, icons and symbols to PCP labels is
another recommended addition. Comprehensibility test-
ing of potential pictograms, however, should be conducted
before any pictograms are legislated for use. For example,
the GHS pictograms were not subjected to global compre-
hensibility testing prior to the development of the first
purple book. Comprehensibility testing, based on the
University of Cape Town’s testing methodology, took
place too late [82] as there was no option for changing
or adapting these pictograms. The GHS building block
approach does, however, allow for countries to add add-
itional pictograms that are relevant for the country context
[5]. We do not recommend introducing more pictograms
with a global scope since pictograms are not cross-
culturally transferable or intuitively obvious [69]. Research
has shown that pictograms are not clearly understood by
consumers - especially the GHS pictogram for acutetoxicity (Figure 1a) [4]. We recommend that a mechanism
be put in place for countries to evaluate and upgrade
legally binding pictograms to improve RC. We there-
fore support the plan proposed by ECHA to perform a
new analysis by 2015 before mixtures will have to be labeled
with the new GHS pictograms [66]. The question of
cross-cultural comprehension of pictograms as scientific-
ally intended is illustrated by whether these are under-
stood in the same way by an illiterate South African farm
worker as by a Finnish professor. Importantly, misinter-
pretations of label information can even increase the health
risk [69]. To reduce misinterpretations, we recommend
clear hazard statements on the label with precautionary
advice. We also recommend that any pictograms or icons
used on labels have the meaning printed in clear and con-
cise words underneath.
As an additional RC mechanism, we propose the
mandatory use of special labelling for PCPs showing
negative effects for skin (proposed GHS 17 in [64])
and eyes through clear and easily understandable pic-
tograms, warning sentences or photographs after con-
ducting comprehensibility research with the intended
consumer audience. Risk information and the potential
dangers could be written in big letters on the packages
of PCPs, similar to the warnings found on tobacco prod-
ucts in the EU [83] and SA or the use of photographs of
irritated skin or eyes (Figure 2), similar to the warnings
on tobacco products in Australia [84]. Although there
could be visual misinterpretation or the consumer may
not know how to use the product while protecting them-
selves, these pictures would aid in addressing literacy issues.
Of course, we suggest such warnings only on those PCPs
containing hazardous substances, not on PCPs in general.
Instead of indicating hazards on the product containers
through language and symbols, another useful RC strategy
is the use of a standardized process for assessing and
recommending the least hazardous products [86]. For
example, the German Allergy and Asthma Association
(Deutscher Allergie- und Asthmabund, DAAB), a non-
governmental consumer organization, recommends prod-
ucts that fulfill stringent criteria and product testing.
Producers of products that comply with these criteria of
the DAAB are then allowed to use the DAAB logo on
their labels (Figure 3). Consumers, taught the meaning
of the logo, can use this process for reducing their expo-
sures to hazardous ingredients.
Education and assistance for consumers
The reality is that no one RC method will be effective for
all populations and an integrated approach, with several
socio-cultural appropriate mechanisms, is needed. Easy
access to information is vital so consumers do not need to
search for what the information means. There are several
methods for improving comprehension and scientifically
i-
Table 2 Compilation of potential P-statements attributed to a small selection of cosmetic product formulas
Product/pictograms and signal word/H statements Corresponding P-statements
Hair spray Prevention:
DANGER
H225 Highly flammable liquid and vapour.
H319 Causes serious eye irritation.
P210 Keep away from heat/sparks/open flames/ho faces. No smoking.
P233 Keep container tightly closed.
P240 Ground/bond container and receiving equipm t.
P241 Use explosion-proof electrical/ventilating/ligh /…/equipment.
P242 Use only non-sparkling tools.
P243 Take precautionary measures against static di rge.
P264 Wash … thoroughly after handling.
P280 Wear protective gloves/protective clothing/ey rotection/face protection.
Response:
P303 + P361 + P353 IF ON SKIN (or hair): Remove/Tak f immediately all contaminated clothing. Rinse skin
with water/shower.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with w for several minutes. Remove contact lenses, if present
and easy to do. Continue rinsing.
P337 + P313 If eye irritation persists: Get medical ad /attention.
P370 + P378 In case of fire: Use … for extinction.
Storage: P403 + P235 Store in a well-ventilated place. p cool.
Disposal: P501 Dispose of contents/container to …
Oxidative hair dye formula Prevention:
DANGER
H314 Causes severe skin burns and eye damage.
H318 Causes serious eye damage.
P260 Do not breathe dust/fume/gas/mist/vapours/ y.
P264 Wash … thoroughly after handling.
P280 Wear protective gloves/protective clothing/ey rotection/face protection.
Response:
P301 + P330 + P331 IF SWALLOWED: Rinse mouth. NOT induce vomiting.
P303 + P361 + P353 IF ON SKIN (or hair): Remove/Tak f immediately all contaminated clothing. Rinse skin
with water/shower.
P304 + P340 If INHALED: Remove victim to fresh ai keep at rest in a position comfortable for breathing.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with w for several minutes. Remove contact lenses, if present
and easy to do. Continue rinsing.
P310 Immediately call a POISON Center or doctor/ ician.
P321 Specific treatment (see … on this label).
P363 Wash contaminated clothing before reuse.
Storage: P405 Store locked up.
































Table 2 Compilation of potential P-statements attributed to a small selection of cosmetic product formulas (Continued)
After shave balm Prevention:
WARNING
H361 Suspected of damaging fertility or the unborn child
P201 Obtain special instructions before use.
P202 Do not handle until all safety precautions have been read and understood.
P281 Use personal protective equipment as required.
Response: P308 + P313 IF exposed or concerned: Get medical advice/attention.
Storage: P405 Store locked up.
Disposal: P501 Dispose of contents/container to …
Perfume Prevention:
DANGER
H315 Causes skin irritation.
H317 May cause an allergic skin reaction.
H318 Causes serious eye damage.
H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled.
H411 Toxic to aquatic life with long-lasting effects.
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P264 Wash … thoroughly after handling.
P272 Contaminated work clothing should not be allowed out of the workplace.
P273 Avoid release to the environment.
P280 Wear protective gloves/protective clothing/eye protection/face protection.
P285 In case of inadequate ventilation, wear respiratory protection.
Response:
P302 + P352 IF ON SKIN: Wash with plenty of soap and water.
P304 + P341 IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable
for breathing.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present
and easy to do. Continue rinsing.
P310 Immediately call a POISON Center or doctor/physician.
P321 Specific treatment (see … on this label).
P332 + P313 If skin irritation occurs: Get medical advice/attention.
P333 + P313 If skin irritation or rash occurs: Get medical advice/attention.
P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician.
P362 Take off contaminated clothing and wash before reuse.
P363 Wash contaminated clothing before reuse.
P391 Collect spillage.
Storage: -

















Table 2 Compilation of potential P-statements attributed to a small selection of cosmetic product formulas (Continued)
Nail glue Prevention:
WARNING
H315 Causes skin irritation.
H319 Causes serious eye irritation.
H335 May cause respiratory irritation.
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P264 Wash…thoroughly after handling.
P271 Use only outdoors or in a well-ventilated area.
P280 Wear protective gloves/protective clothing/eye protection/face protection.
Response:
P302 + P352 IF ON SKIN: Wash with plenty of soap and water.
P304 + P340 IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present
and easy to do. Continue rinsing.
P312 Call a POISON CENTER or doctor/physician if you feel unwell.
P321 Specific treatment (see … on this label).
P332 + P313 If skin irritation occurs: Get medical advice/attention.
P337 + P313 If eye irritation persists: Get medical advice/attention.
P362 Take off contaminated clothing and wash before reuse.
Storage:
P403 + P233 Store in a well-ventilated place. Keep container tightly closed.
P405 Store locked up.
Disposal:
P501 Dispose of contents/container to…

















Figure 2 Examples of tobacco product labels and proposal for self-explanatory label for deodorant containing skin sensitizers or
irritants. (a) Examples of tobacco product labels in Australia according to the Australian Tobacco Plain Packaging Bill [84]. (b) Proposal for a
self-explanatory label for a deodorant containing skin sensitizers or irritants. The photograph of the axilla shows a patient with severe contact allergy
to fragrance ingredients in deodorants (photograph by P.J. Frosch published in [85]).
Figure 3 The logo of the German Allergy and Asthma
Association (Deutscher Allergie- und Asthmabund, DAAB). It
serves as indicator for PCPs recommended by the DAAB for patients
suffering from skin or respiratory problems.
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teaching how to read a PCP label in primary schools, pro-
viding brochures and posters next to where PCPs are sold
aiding consumers in reading labels, providing telephone
numbers on labels to an independent helpline that
can answer questions and including label reading/
comprehension in popular media. People who use or are
exposed to PCPs on a professional basis should receive
sufficient training and physicians should provide at-risk
patients with relevant information. Also, some companies
(e.g., the German Cosmetic, Toiletry, Perfumery and
Detergent Association [Industrieverband Körperpflege- und
Waschmittel. IKW] and the European Cosmetics Associ-
ation [COLIPA]) could provide detailed and useful infor-
mation on their homepages, e.g., about the safety of
products and the legislation (www.ikw.org, www.cosmetic-
seurope.eu). People suffering from contact allergy to cos-
metic ingredients can also find help in medical allergy
centers. There is further help by several consumer organiza-
tions, besides the above-mentioned DAAB. For example, theenvironmental organization Bund für Umwelt und Nat-
urschutz (BUND) in Germany has developed an elec-
tronic app to identify PCPs with endocrine-disrupting
ingredients (www.bund.net/toxfox). Most consumer or-
ganizations rely on the ingredient lists on the products.
However, if the lists are incomplete [10,72,87], they are
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work of consumer organizations can also improve RC
and we recommend that they should be supported by
national authorities.
Box: study highlights
The following are the highlights of this study:
 PCPs ingredient lists are not a suitable RC
instrument for consumers in the European Union or
South Africa, as they place too much responsibility
on the consumer and are more beneficial to trade.
 EU guidance for RC is not implemented for PCPs.
The exception clause for PCPs in the CLP
Regulation does not go in line with a decent RC.
 The huge efforts of data collection for REACH and
CLP should be used for the benefit for the
consumers and the environment.
 The ‘right to know’ should also be applied to PCPs. As
long as hazardous substances are present in PCPs,
clear labels are needed for consumer information.
 Routine RC implies a proactive communication with
the general public. Effective RC implies a
combination of several RC instruments depending
on the target groups.
 Independent controls are needed to control whether
the aims of a RC instruments were achieved, leading
eventually to readjustments of the instruments.
Conclusion
PCPs play an important role in everyday life for personal
hygiene and wellness. However, it must be questioned
whether the benefits outweigh any negative health and
environmental effects. Furthermore, public awareness is
low in regard to the hidden costs to human health or the
environment due to their hazardous ingredients. Only a
minority are informed of these risks (e.g., producers, med-
ical doctors specialized in allergies, patients, environmen-
talists, or scientists working in this field). Therefore, there
is an urgent need for how risks are communicated
and the comprehension of this information to be im-
proved for consumers (see ‘Box: study highlights’
section).
Several recommendations were presented for improving
RC and reducing the risks posed by PCPs. Efficient RC
and risk mitigation would not only reduce the number
of people suffering from negative health effects but they
also would help save costs for the health care systems
and environmental remediation. They should be imple-
mented as an integrated management strategy rather than
focusing on only one approach to improve the situation.
The ingredient lists on the containers of PCPs give
valuable information for people who need or want to
avoid certain ingredients. However, for the generalconsumers, the list of ingredients cannot be regarded as
an effective RC method. ‘Read this!’ does not guarantee
the users’ safety.
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